Clinical Study Results
How many participants had adverse reactions?
There were 4.3% of participants who had adverse reactions during the study. This was
10 out of 233 participants.
There were 0.4% of participants who stopped treatment because of adverse reactions
they had during the study. This was 1 out of 233 participants. This participant was in the
benralizumab treatment group and stopped treatment because of the adverse reaction of
allergic reaction.
The table below shows how many participants had adverse reactions during the study.
Adverse reactions during the study
30 mg
Benralizumab Placebo Total
(out of 118 (out of 115 (out of 233
participants) participants) participants)
How many participants had adverse
5.9% (7) 2.6% (3) 4.3% (10)
reactions during the study?
How many participants stopped
0.8% (1) 0.0% (0) 0.4% (1)
treatment because of adverse reactions?
6